Takeda Pharmaceutical Co (TSE:4502) Long-Term Debt : 円4,293,872 Mil (As of Dec. 2023)

View and export this data going back to 1949. Start your Free Trial

What is Takeda Pharmaceutical Co Long-Term Debt?

Takeda Pharmaceutical Co's Long-Term Debt for the quarter that ended in Dec. 2023 was 円4,293,872 Mil.

Takeda Pharmaceutical Co's quarterly Long-Term Debt increased from Jun. 2023 (円4,330,254 Mil) to Sep. 2023 (円4,404,363 Mil) but then declined from Sep. 2023 (円4,404,363 Mil) to Dec. 2023 (円4,293,872 Mil).

Takeda Pharmaceutical Co's annual Long-Term Debt declined from Mar. 2021 (円4,613,218 Mil) to Mar. 2022 (円4,141,418 Mil) and declined from Mar. 2022 (円4,141,418 Mil) to Mar. 2023 (円4,042,741 Mil).

Takeda Pharmaceutical Co Long-Term Debt Historical Data

The historical data trend for Takeda Pharmaceutical Co's Long-Term Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Takeda Pharmaceutical Co Long-Term Debt Chart

Takeda Pharmaceutical Co Annual Data

Trend

Mar14

Mar15

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Long-Term Debt

Get a 7-Day Free Trial

4,766,005.00

4,506,487.00

4,613,218.00

4,141,418.00

4,042,741.00

Takeda Pharmaceutical Co Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Long-Term Debt	Get a 7-Day Free Trial															3,914,884.00	4,042,741.00	4,330,254.00	4,404,363.00	4,293,872.00

Takeda Pharmaceutical Co (TSE:4502) Long-Term Debt Explanation

Long-Term Debt is the sum of the carrying values as of the balance sheet date of all long-term debt, which is debt initially having maturities due after one year or beyond the operating cycle, if longer, but excluding the portions thereof scheduled to be repaid within one year or the normal operating cycle, if longer. Long-Term Debt includes notes payable, bonds payable, mortgage loans, convertible debt, subordinated debt and other types of long term debt.

Takeda Pharmaceutical Co Long-Term Debt Related Terms

Thank you for viewing the detailed overview of Takeda Pharmaceutical Co's Long-Term Debt provided by GuruFocus.com. Please click on the following links to see related term pages.

Takeda Pharmaceutical Co (TSE:4502) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Takeda Pharmaceutical Co Ltd (TSE:4502) » Definitions » Long-Term Debt

Comparable Companies

Traded in Other Exchanges

TAK:USA TKPHF:USA TAK:Mexico TKD:Germany TAKP34:Brazil

Address

1-1, Nihonbashi-Honcho 2-Chome, Chuo-ku, Tokyo, JPN, 103-8668

Website

https://www.takeda.com

Takeda Pharmaceutical is Japan's largest pharmaceutical company, with revenue of JPY 4 trillion in fiscal 2022. The company's five core therapeutic areas are oncology, gastroenterology, neuroscience, rare diseases, and plasma-derived therapies, which account for more than 80% of revenue. Its geographic footprint is well diversified, with 50% derived from the U.S., 20% from Japan, 20% from Europe and Canada.

Takeda Pharmaceutical Co (TSE:4502) Headlines

No Headlines